Specify a stock or a cryptocurrency in the search bar to get a summary
Captor Therapeutics S.A.
CTXCaptor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. It has various therapeutic molecules in the preclinical stage. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland. Address: ul. Dunska 11, Wroclaw, Poland, 54-427
Analytics
WallStreet Target Price
461.34 PLNP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures CTX
Dividend Analytics CTX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CTX
Stock Valuation CTX
Financials CTX
Results | 2019 | Dynamics |